STAR2023-10-012023-12-31 STAR2023-10-012023-12-31 STAR2023-10-012023-12-31in-bse-fin:OneOperatingExpenses01Member STAR2023-10-012023-12-31in-bse-fin:FourOperatingExpenses01Member STAR2023-12-31 STAR2023-10-012023-12-31in-bse-fin:OneReportableSegmentRevenue01Member STAR2023-10-012023-12-31in-bse-fin:OneReportableSegmentRevenue02Member STAR2023-10-012023-12-31in-bse-fin:FourReportableSegmentRevenue01Member STAR2023-10-012023-12-31in-bse-fin:FourReportableSegmentRevenue02Member STAR2023-10-012023-12-31in-bse-fin:OneReportableSegmentResults01Member STAR2023-10-012023-12-31in-bse-fin:OneReportableSegmentResults02Member STAR2023-10-012023-12-31in-bse-fin:FourReportableSegmentResults01Member STAR2023-10-012023-12-31in-bse-fin:FourReportableSegmentResults02Member STAR2023-10-012023-12-31in-bse-fin:OneReportableSegmentAssets01Member STAR2023-10-012023-12-31in-bse-fin:OneReportableSegmentAssets02Member STAR2023-10-012023-12-31in-bse-fin:OneReportableSegmentLiabilities01Member STAR2023-12-31in-bse-fin:OneReportableSegmentLiabilities01Member STAR2023-10-012023-12-31in-bse-fin:OneReportableSegmentLiabilities02Member STAR2023-12-31in-bse-fin:OneReportableSegmentLiabilities02Member STAR2023-10-012023-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member STAR2023-10-012023-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member STAR2023-10-012023-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member STAR2023-10-012023-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member STAR2023-10-012023-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member STAR2023-10-012023-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 532531 STAR NOTLISTED Strides Pharma Science Limited Equity 2023-04-01 2024-03-31 2024-01-30 2024-01-22 INR Millions Third quarter 11:45:00 13:10:00 2024-01-30 2024-01-30 Not applicable Multi segment 2023-10-01 2023-12-31 Unaudited Consolidated 10376680000.00 87540000.00 10464220000.00 3751280000.00 506640000.00 -45500000.00 1844940000.00 792840000.00 512280000.00 2381210000.00 9743690000.00 720530000.00 -100670000.00 619860000.00 37180000.00 63840000.00 101020000.00 0.00 518840000.00 541480000.00 0.00 541480000.00 -519740000.00 540580000.00 61340000.00 601920000.00 496670000.00 43910000.00 596000000.00 5920000.00 918860000.00 10 -0.49 -0.49 5.92 5.91 5.43 5.42 Multi segment 2023-04-01 2023-12-31 Unaudited Consolidated 29670890000.00 532470000.00 30203360000.00 9872770000.00 1708070000.00 661960000.00 5519560000.00 2342890000.00 1709230000.00 6773230000.00 28587710000.00 1615650000.00 -1809740000.00 -194090000.00 248270000.00 -124880000.00 123390000.00 0.00 -317480000.00 541480000.00 0.00 541480000.00 -1271570000.00 -1047570000.00 -13950000.00 -1061520000.00 -887890000.00 -159680000.00 -873350000.00 -188170000.00 918860000.00 10 -15.76 -15.76 5.97 5.97 -9.79 -9.79 Other Expenses 2381210000.00 Other Expenses 6773230000.00 Bio-pharmaceutical business 0.00 Pharmaceutical business 10376680000.00 Bio-pharmaceutical business 0.00 Pharmaceutical business 29670890000.00 10376680000.00 29670890000.00 10376680000.00 29670890000.00 Bio-pharmaceutical business -394078000.00 Pharmaceutical business 1287038000.00 Bio-pharmaceutical business -1082073000.00 Pharmaceutical business 1959303000.00 892960000.00 877230000.00 792840000.00 2342890000.00 100120000.00 -1465660000.00 Bio-pharmaceutical business 1975800000.00 Pharmaceutical business 59890720000.00 61866520000.00 Bio-pharmaceutical business 0.00 Pharmaceutical business 40793460000.00 40793460000.00 Items that will not be reclassified to statement of profit and loss 3170000.00 Items that will not be reclassified to statement of profit and loss -13520000.00 3170000.00 -13520000.00 -40000.00 -250000.00 Items that may be reclassified to statement of profit and loss 21040000.00 Income tax relating to items that may be reclassified to profit or loss 37090000.00 Items that may be reclassified to statement of profit and loss 11070000.00 Income tax relating to items that may be reclassified to profit or loss -11750000.00 58130000.00 -680000.00 0.00 0.00